MedPage Today March 6, 2021
— Swift federal action can remove barriers to life-saving treatment
There have been scant opportunities for optimism in the past year. COVID-19 has taken so much from us – our loved ones, our economic security, our sense of community. One positive in the midst of this chaos came in the form of an underreported policy change from HHS. On January 14, Admiral Brett Giroir of HHS announced relaxation of restrictions around prescribers’ ability to provide medication-assisted treatment (MAT) for opioid use disorder (OUD). Specifically, the new rule removed the need for providers to obtain an “X-waiver” from the Drug Enforcement Administration (DEA) to prescribe buprenorphine.
The X-waiver represents an enormous barrier to effectively addressing the nation’s opioid use emergency. With...
Today's Sponsors
Today's Sponsor